Rapid Micro Biosystems (RPID) Cash from Investing Activities (2020 - 2026)

Rapid Micro Biosystems has reported Cash from Investing Activities for 7 years, with the latest figure at $8.6 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 19.52% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (down 63.8% YoY) and the FY2025 annual result came in at $14.3 million, down 60.91% from the prior year.
• Cash from Investing Activities improved to $8.6 million in Q1 2026 per RPID's latest filing, from $3.9 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $24.8 million in Q2 2024 and troughed at -$99.5 million in Q1 2022.
• A 5-year average of $486235.3 and a median of $8.6 million in 2026 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities sank 1846.41% in 2022, then soared 508.63% in 2023.
• Over 5 years, Cash from Investing Activities stood at $12.8 million in 2022, then declined by 21.81% to $10.0 million in 2023, then plunged by 51.41% to $4.9 million in 2024, then fell by 20.07% to $3.9 million in 2025, then soared by 121.15% to $8.6 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $8.6 million, $3.9 million, and -$9.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.